TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Genor Biopharma Holdings Limited ( (HK:6998) ) is now available.
Genor Biopharma Holdings Limited has announced a series of significant corporate actions, including a proposed merger and a reverse takeover, which involve the issuance of consideration shares and a new listing application. The company is also seeking a whitewash waiver and plans to increase its authorized share capital and adopt a one-off share option plan. The dispatch of the circular related to these transactions has been delayed, with the company working closely with regulators to address comments and finalize the information. The proposed merger and associated actions are subject to various conditions and approvals, and shareholders are advised to exercise caution.
More about Genor Biopharma Holdings Limited
Genor Biopharma Holdings Limited is a company incorporated in the Cayman Islands, primarily operating in the biopharmaceutical industry. The company focuses on the development and commercialization of innovative biologics, with a market focus on oncology and autoimmune diseases.
Average Trading Volume: 1,611,925
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.82B
For a thorough assessment of 6998 stock, go to TipRanks’ Stock Analysis page.